Chin_2022_Cureus_14_e31065

Reference

Title : Conventional Versus New Treatment: Comparing the Effects of Acetylcholinesterase Inhibitors and N-Methyl-D-Aspartate Receptor Antagonist With Aducanumab - Chin_2022_Cureus_14_e31065
Author(s) : Chin E , Jaqua E , Safaeipour M , Ladue T
Ref : Cureus , 14 :e31065 , 2022
Abstract : Chin_2022_Cureus_14_e31065
ESTHER : Chin_2022_Cureus_14_e31065
PubMedSearch : Chin_2022_Cureus_14_e31065
PubMedID: 36475205

Related information

Citations formats

Chin E, Jaqua E, Safaeipour M, Ladue T (2022)
Conventional Versus New Treatment: Comparing the Effects of Acetylcholinesterase Inhibitors and N-Methyl-D-Aspartate Receptor Antagonist With Aducanumab
Cureus 14 :e31065

Chin E, Jaqua E, Safaeipour M, Ladue T (2022)
Cureus 14 :e31065